New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
07:03 EDTINSYInsys Therapeutics completes human abuse study for Dronabinol Oral Solution
Insys Therapeutics announced the successful completion of a human abuse study for Dronabinol Oral Solution, its proprietary, orally administered liquid formulation of the synthetic cannabinoid dronabinol in development for the treatment of chemotherapy induced nausea and vomiting, or CINV, and anorexia associated with weight loss in patients with AIDS.
News For INSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
08:52 EDTINSYInsys Therapeutics price target raised to $46 from $38 at Piper Jaffray
Subscribe for More Information
June 25, 2015
11:09 EDTINSYInsys sinks after nurse pleads guilty to receiving kickbacks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use